Omnicare Inc (OCR): Today's Featured Wholesale Laggard
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
.
(
) pushed the Wholesale industry lower today making it today's featured Wholesale laggard. The industry as a whole closed the day down 0.4%. By the end of trading, Omnicare fell 64 cents (-1.9%) to $33.84 on average volume. Throughout the day, 929,831 shares of Omnicare exchanged hands as compared to its average daily volume of one million shares. The stock ranged in price between $33.77-$34.60 after having opened the day at $34.27 as compared to the previous trading day's close of $34.48. Other companies within the Wholesale industry that declined today were:
(
), down 10.8%,
(
), down 9.3%,
(
), down 6.5%, and
(
), down 5.3%.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States and Canada. Omnicare has a market cap of $3.78 billion and is part of the services sector. The company has a P/E ratio of 19.1, above the S&P 500 P/E ratio of 17.7. Shares are up 0.1% year to date as of the close of trading on Friday. Currently there are five analysts that rate Omnicare a buy, no analysts rate it a sell, and three rate it a hold.
TheStreet Ratings rates Omnicare as a
. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins.
- You can view the full Omnicare Ratings Report.
- Use our wholesale section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the wholesale industry could consider
iShares Dow Jones US Cons Goods
(
) while those bearish on the wholesale industry could consider
ProShares Ultra Sht Consumer Goods
(
).
- Find other investment ideas from our top rated ETFs lists.
FREE for a limited time only: Get TheStreet Ratings #1 Stock Report NOW!
.
null